SCHEMBL20112166

SCHEMBL20112166

Cc1ccc(C2=CCN(C(=O)OC(C)(C)C)CC2)c(C)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK4 Q16654 1/20 0.58
GRM1 Q13255 11/20 0.53
GRM5 P41594 10/20 0.53
GABRP O00591 1/20 0.52
GABRD O14764 1/20 0.52
GABRA1 P14867 1/20 0.52
GABRB1 P18505 1/20 0.52
GABRG2 P18507 1/20 0.52
GABRB3 P28472 1/20 0.52
GABRA5 P31644 1/20 0.52
GABRA3 P34903 1/20 0.52
GABRA2 P47869 1/20 0.52
GABRB2 P47870 1/20 0.52
GABRA4 P48169 1/20 0.52
GABRE P78334 1/20 0.52
GABRA6 Q16445 1/20 0.52
GABRG1 Q8N1C3 1/20 0.52
GABRG3 Q99928 1/20 0.52
GABRQ Q9UN88 1/20 0.52
HTR6 P50406 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25936245 0.90 PDK4 (0.56) PDK4GRM1GRM5GABRPGABRD
SCHEMBL12713080 0.90 PDK4 (0.58) PDK4GRM1GRM5GABRPGABRD
SCHEMBL1811363 0.89 PDK4 (0.55) PDK4GRM1GRM5GABRPGABRD
SCHEMBL16434777 0.89 GRM1 (0.56) PDK4GRM1GRM5GABRPGABRD
SCHEMBL29744827 0.89 PDK4 (0.55) PDK4GRM1GRM5GABRPGABRD
SCHEMBL19701841 0.89 CNR1 (0.55) PDK4GRM1GRM5GABRPGABRD
SCHEMBL25257677 0.87 PDK4 (0.53) PDK4GRM1GRM5GABRPGABRD
SCHEMBL19297110 0.87 PDK4 (0.53) PDK4GRM1GRM5GABRPGABRD
SCHEMBL24669310 0.87 PDK4 (0.53) PDK4GRM1GRM5GABRPGABRD
SCHEMBL3539792 0.86 PDK4 (0.57) PDK4GRM1GRM5GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10961238-B2 Modulators of hedgehog (Hh) signaling pathway E-THERAPEUTICS PLC (GB) 2021-03-30 US disclosed
US-20200055847-A1 MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY E-THERAPEUTICS PLC (GB) 2020-02-20 US disclosed
WO-2019043372-A1 SUBSTITUTES SULFONYL AZACYCLES AS MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY E-THERAPEUTICS PLC (GB) 2019-03-07 WO disclosed
WO-2018078360-A1 MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY E-THERAPEUTICS PLC (GB) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10961238-B2 Modulators of hedgehog (Hh) signaling pathway SHH, GLI1, SMO PDK4 3581/4885GRM1 488/4885GRM5 581/4885
US-20200055847-A1 MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY SHH, GLI1, SMO PDK4 3556/4885GRM1 471/4885GRM5 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.